Author:
Chadi Alexandre,Thirion Daniel J. G.,David Pierre-Marie
Abstract
Abstract
Context
Social determinants of health are drivers of vaccine inequity and lead to higher risks of complications from infectious diseases in under vaccinated communities. In many countries, pharmacists have gained the rights to prescribe and administer vaccines, which contributes to improving vaccination rates. However, little is known on how they define and target vulnerable communities.
Objective
The purpose of this study is to describe how vulnerable communities are targeted in community pharmacies.
Methods
We performed a systematic search of the Embase and MEDLINE database in August 2021 inspired by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses protocols (PRISMA ScR). Articles in English, French or Spanish addressing any vaccine in a community pharmacy context and that target a population defined as vulnerable were screened for inclusion.
Results
A total of 1039 articles were identified through the initial search, and 63 articles met the inclusion criteria. Most of the literature originated from North America (n = 54, 86%) and addressed influenza (n = 29, 46%), pneumococcal (n = 14, 22%), herpes zoster (n = 14, 22%) or human papilloma virus vaccination (n = 14, 22%). Lifecycle vulnerabilities (n = 48, 76%) such as age and pregnancy were most often used to target vulnerable patients followed by clinical factors (n = 18, 29%), socio-economical determinants (n = 16, 25%) and geographical vulnerabilities (n = 7, 11%). The most frequently listed strategy was providing a strong recommendation for vaccination, promotional posters in pharmacy, distributing leaflet/bag stuffers and providing staff training. A total of 24 barriers and 25 facilitators were identified. The main barriers associated to each vulnerable category were associated to effective promotional strategies to overcome them.
Conclusion
Pharmacists prioritize lifecycle and clinical vulnerability at the expense of narrowing down the definition of vulnerability. Some vulnerable groups are also under targeted in pharmacies. A wide variety of promotional strategies are available to pharmacies to overcome the specific barriers experienced by various groups.
Funder
Sanofi chair in ambulatory pharmaceutical care of Montreal University
Pfizer propulsed by MITCAS
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health
Reference116 articles.
1. WHO. Vaccine Equity. 2022. Accessed 3 Jan 2023. https://www.who.int/campaigns/vaccine-equity .
2. Amin K, Ortaliza J, Cox C, Michaud J, Kates J. COVID-19 preventable mortality. KFF. Published April 21, 2022. Accessed 3 Jan 2023. https://www.kff.org/coronavirus-covid-19/issue-brief/covid-19-continues-to-be-a-leading-cause-of-death-in-the-u-s/.
3. Walsh B, Doherty E, O’Neill C. Since The Start Of The Vaccines For Children Program, Uptake Has Increased, And Most Disparities Have Decreased. Health Aff. 2016;35(2):356–64. https://doi.org/10.1377/hlthaff.2015.1019.
4. O’Halloran AC, Holstein R, Cummings C, et al. Rates of Influenza-Associated Hospitalization, Intensive Care Unit Admission, and In-Hospital Death by Race and Ethnicity in the United States From 2009 to 2019. JAMA Network Open. 2021;4(8):e2121880. https://doi.org/10.1001/jamanetworkopen.2021.21880.
5. Wold B, Mittelmark MB. Health-promotion research over three decades: The social-ecological model and challenges in implementation of interventions. Scand J Public Health. 2018;46(20_suppl):20–6. https://doi.org/10.1177/1403494817743893.